Contact this trialFirst, we need to learn more about you.
Platinum-containing compounds
Durvalumab + Chemo/Radiation for Bladder Cancer
Recruiting1 awardPhase 2
Des Moines, Iowa
This trial is testing if adding the immunotherapy drug durvalumab to standard chemotherapy and radiation therapy helps treat bladder cancer that has spread to the lymph nodes better than standard chemotherapy and radiation therapy alone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.